SayPro Applicants should provide in their proposal sufficient preliminary evidence, including relevant methodology(ies) and high-quality data to demonstrate that the biomarker(s) and/or technology(ies) can be progressed towards clinical validation and, when relevant, to regulatory acceptance.

South African rand (R) - ZAR
  • South African rand (R) - ZAR
  • United States dollar ($) - USD
  • Euro (€) - EUR

Description

Reviews

There are no reviews yet.

Be the first to review “SayPro Applicants should provide in their proposal sufficient preliminary evidence, including relevant methodology(ies) and high-quality data to demonstrate that the biomarker(s) and/or technology(ies) can be progressed towards clinical validation and, when relevant, to regulatory acceptance.”

Vendor Information

  • No ratings found yet!